封面
市場調查報告書
商品編碼
1701725

感染控制市場規模、佔有率、成長分析(按產品、按應用、按分銷管道、按最終用戶、按地區)-2025 年至 2032 年產業預測

Infection Control Market Size, Share, and Growth Analysis, By Product, By Application, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023 年感染控制市場規模價值 492 億美元,預計將從 2024 年的 525.9 億美元成長到 2032 年的 896.9 億美元,預測期內(2025-2032 年)的複合年成長率為 6.9%。

由於外科手術和治療程序的增加,感染控制市場正在經歷顯著成長,這些程序強調感染控制以獲得成功的臨床結果。 COVID-19 疫情增加了醫療機構、製藥公司和醫療設備製造商對消毒滅菌的需求,導致美國消毒劑產量增加了 60%。滅菌方法的技術進步和外包滅菌服務的成長趨勢進一步促進了市場擴張。此外,政府旨在加強感染預防措施的措施以及世界衛生組織 (WHO) 等組織的全球指導方針也在提高人們的認知並加強預防行為。隨著這一成長勢頭,預計感染控制市場在未來幾年將經歷強勁成長。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 二次資料和一次資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 限制與挑戰
  • 波特的分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024年)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 技術分析
  • 監管分析

感染控制市場規模:依產品及複合年成長率(2025-2032)

  • 市場概覽
  • 無菌產品
    • 熱滅菌器
    • 濕熱滅菌器
    • 乾熱滅菌器
    • 巴氏殺菌機
    • 放射線殺菌
  • 清潔和消毒產品
    • 消毒器
    • 洗衣機消毒器
    • 閃光消毒劑
    • 其他
    • 內視鏡再處理系統
    • 高階內視鏡再處理系統
    • 中型內視鏡再處理系統
    • 低階內視鏡再處理系統
  • 個人防護屏障
  • 內視鏡再處理產品
  • 抗菌表面
  • 其他感染控制產品

感染控制市場規模:依應用和複合年成長率(2025-2032)

  • 市場概覽
  • 手術器械
  • 內視鏡檢查
  • 超音波探頭
  • 其他

感染控制市場規模(依分銷管道分類)及複合年成長率(2025-2032)

  • 市場概覽
  • 直接競標
  • 零售銷售
  • 第三方經銷商

感染控制市場規模(依最終用戶和複合年成長率) (2025-2032)

  • 市場概覽
  • 醫院
  • 診所
  • 醫療設備公司
  • 製藥和生物技術公司
  • 研究所
  • 其他

感染控制市場規模:按地區及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024年)
  • 主要企業簡介
    • 公司詳情
    • 產品系列分析
    • 公司分部佔有率分析
    • 收益與前一年同期比較對比(2022-2024 年)

主要企業簡介

  • 3M Company(USA)
  • Ecolab Inc.(USA)
  • Getinge AB(Sweden)
  • STERIS plc(Ireland)
  • Fortive Corporation(USA)
  • Cardinal Health, Inc.(USA)
  • Medline Industries, LP(USA)
  • Paul Hartmann AG(Germany)
  • Becton, Dickinson and Company(BD)(USA)
  • Johnson & Johnson(USA)
  • MMM Group(Germany)
  • Belimed AG(Switzerland)
  • Envista Holdings Corporation(USA)
  • SC Johnson Professional(USA)
  • Reckitt Benckiser Group plc(UK)
  • Gojo Industries, Inc.(USA)
  • Diversey Holdings, Ltd.(USA)

結論和建議

簡介目錄
Product Code: SQMIG35A2623

Infection Control Market size was valued at USD 49.2 billion in 2023 and is poised to grow from USD 52.59 billion in 2024 to USD 89.69 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The infection control market is experiencing significant growth driven by an increase in surgical and therapeutic procedures emphasizing infection management for successful clinical outcomes. The COVID-19 pandemic has heightened the demand for sterilization and disinfection across healthcare facilities, pharmaceutical companies, and medical device manufacturers, with sanitizer production in the U.S. rising by 60%. Technological advancements in sterilization methods and the growing trend of outsourcing sterilization services further contribute to market expansion. Additionally, government initiatives aimed at promoting heightened infection prevention measures and global guidelines from organizations like the World Health Organization are also fostering awareness and enhancing preventive actions. This collective momentum positions the infection control market for robust growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infection Control Market Segments Analysis

Global Infection Control Market is segmented by Product, Application, Distribution Channel, End User and region. Based on Product, the market is segmented into Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-Microbial Surfaces and Other Infection Control Products. Based on Application, the market is segmented into Surgical Instruments, Endoscopes, Ultrasound Probes and Others. Based on Distribution Channel, the market is segmented into Direct Tender, Retail Sales and Third Party Distributors. Based on End User, the market is segmented into Hospitals, Clinics, Medical Device Companies,Pharmaceuticaland Biotechnology Companies, Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infection Control Market

The Infection Control market is significantly driven by the escalating prevalence of healthcare-associated infections. This rise has heightened awareness among healthcare providers regarding the critical importance of effective infection prevention strategies, as these infections affect millions of patients annually. Consequently, there has been a surge in expenditure related to infection control practices and consumables, including personal protective equipment (PPE), disinfectants, and sterilization tools. Healthcare organizations are now adopting a comprehensive approach to infection control, prioritizing patient safety and the quality of care. As a result, there is an increasing demand for innovative solutions designed to minimize infection risks and enhance overall healthcare delivery.

Restraints in the Infection Control Market

One significant restraint in the infection control market is the high cost associated with advanced technologies. Implementing effective infection control strategies often necessitates substantial investments in sophisticated equipment, ongoing maintenance, and staff training. Smaller healthcare facilities may struggle to afford these essential solutions, which can hinder their ability to adhere to proper infection control protocols. Consequently, the financial burden posed by these expenditures can stifle market expansion and limit the adoption of innovative products and technologies. As many companies grapple with the challenge of delivering cost-effective infection control measures that meet stringent quality standards, this situation poses barriers to overall market growth.

Market Trends of the Infection Control Market

The Infection Control market is witnessing a significant trend towards high-tech advancements, driven by the increasing adoption of automation and digitalization in healthcare settings. Healthcare institutions are leveraging smart technologies, including automatic disinfection systems and real-time monitoring solutions, to enhance their infection prevention measures. These innovations streamline processes and provide crucial insights for compliance tracking and identifying improvement areas. As technology becomes embedded in infection control strategies, it is anticipated that patient safety and operational efficiency will experience a transformative boost, reshaping the landscape of infection management and positioning technology at the forefront of infection control initiatives.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Regulatory Analysis

Global Infection Control Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Sterilization Products
    • Heat Sterilization Equipment
    • Moist Heat Sterilization Equipment
    • Dry Heat Sterilization Equipment
    • Low-Temperature Sterilization Equipment
    • Radiation Sterilization Equipment
  • Cleaning and Disinfection Products
    • Disinfector
    • Washer Disinfector
    • Flusher Disinfector
    • Others
    • Endoscopic Reprocessor Systems
    • High-End Endoscopic Reprocessor Systems
    • Mid-Range Endoscopic Reprocessor Systems
    • Low-End Endoscopic Reprocessor Systems
  • Personal Protective Barriers
  • Endoscope Reprocessing Products
  • Anti-Microbial Surfaces
  • Other Infection Control Products

Global Infection Control Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Surgical Instruments
  • Endoscopes
  • Ultrasound Probes
  • Others

Global Infection Control Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Direct Tender
  • Retail Sales
  • Third Party Distributors

Global Infection Control Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Medical Device Companies
  • Pharmaceutical and Biotechnology Companies
  • Laboratories
  • Others

Global Infection Control Market Size & CAGR (2025-2032)

  • North America (Product, Application, Distribution Channel, End User)
    • US
    • Canada
  • Europe (Product, Application, Distribution Channel, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, Distribution Channel, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • 3M Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ecolab Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • STERIS plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fortive Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, LP (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Paul Hartmann AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MMM Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Belimed AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Envista Holdings Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SC Johnson Professional (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gojo Industries, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diversey Holdings, Ltd. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations